Clinical Trial Update: Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating standard of care therapy with involved field radiation therapy for selective recurrent ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Yonsei University | Conditions: Recurrent Ovarian Cancer | Phase 2 | Status: UNKNOWN